Embrapii allocates BRL 20 million for the production of pharmaceuticals and biopharmaceuticals
Non-refundable funds, in the amount of R$ 20 million, are available at the four new units of the Brazilian Company for Research and Industrial Innovation (Embrapii) for the development of new drugs